- Erratum
- Open access
- Published:
Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells
BMC Cancer volume 16, Article number: 374 (2016)
The Original Article was published on 27 May 2014
Erratum
Unfortunately, the original version of this article [1] contained an error within Fig. 5. For testing Sema4D protein expression in PaTu8988 cells with/out SAHA treatment, the protein samples of Fig. 2D were re-tested by Western blot assay using Sema4D antibody (Fig. 5E). The correct version of Fig. 5E can be found below. This does not alter the conclusion of the result.
PaTu8988 cells were incubated with SAHA at indicated dosage for 48Â hours, the protein expressions of Sema4D and tubulin were tested by Western blots. Experiments in this figure were repeated three times, and similar results were obtained. e SAHA suppresses PaTu8988 cell vasculogenic mimicry (VM)
References
Xu X, Yang L, Zheng L, Pan Y, Cao Z, Zhang Z, Zhou Q, et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer. 2014;14:373. doi:10.1186/1471-2407-14-373.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The online version of the original article can be found under doi:10.1186/1471-2407-14-373.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Xu, Xd., Yang, L., Zheng, Ly. et al. Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer 16, 374 (2016). https://doi.org/10.1186/s12885-016-2401-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-016-2401-3